Background: Giant cell arteritis (GCA) is the most common vasculitis among patients age >50 years in north European countries. Although ethnic factors and age clearly play a role, the etiology of the disease is largely unknown. Studies of predictors are therefore of major interest. A meta-analysis of observational studies demonstrated that patients with GCA have a significantly reduced prevalence of diabetes at the time of diagnosis (1). Objectives: To investigate metabolic features prior to diagnosis of GCA in a nested case-control study. Methods: Individuals who developed GCA after inclusion in a population-based health survey (the Malmö Preventive Medicine Project; N=33346) were identified by linking the health survey database to the local patient administrative register and the national patient register. A structured review of medical records was performed. Four controls for every validated case, matched for sex, year of birth and year of screening, were selected from the database. Fasting blood samples had been obtained and analyzed using standard methods as part of the health survey. Potential predictors of GCA were examined in conditional logistic regression models. Results: There were 76 cases with a confirmed clinical diagnosis of GCA (61% female; 65% biopsy positive; 95% fulfilled the ACR criteria for GCA). The mean age at diagnosis was 70 years, and the median time from screening to diagnosis was 20 years (range 2-32). The cases had significantly lower fasting blood glucose (fB-glucose) at baseline screening compared to controls [mean 4.7 vs 5.1 mmol/l, odds ratio (OR) 0.49 per mmol/l; 95% confidence interval (CI) 0.30-0.79]. Current smokers had a reduced risk of GCA (OR 0.35; 95% CI 0.18-0.70). The negative association between baseline fB-glucose and GCA remained significant in analysis adjusted for smoking (OR 0.46 per mmol/l; 95% CI 0.28-0.76). Both cholesterol (mean 5.6 vs 6.0 mmol/l) and triglyceride levels (median 1.0 vs 1.2 mmol/l) were lower among the cases at baseline screening, with significant negative associations with subsequent GCA in crude and smoking-adjusted (ORs with 95% CIs 0.66 per mmol/l; 0.46-0.94 for cholesterol, 0.33 per mmol/l; 0.16-0.69 for triglycerides) models. The effect of fB-glucose on the risk of GCA was stronger in men compared to women (smoking-adjusted ORs per mmol/l 0.11; 95% CI 0.03-0.37, and 0.77; 95% CI 0.50-1.18, respectively). Apart from this, results were similar in women and men. Conclusions: Development of GCA was associated with lower fB-glucose, lower cholesterol and triglyceride levels at baseline, all adjusted for current smoking. These findings are in line with the previous findings of a reduced prevalence of diabetes mellitus at the time of diagnosis of GCA (1). This suggests that metabolic factors influence the development of GCA. Background: Few studies have examined predictors of giant cell arteritis (GCA). A negative association between body mass index (BMI) and development of GCA has been reported (1, 2). There is limited information on the impact of smoking and socioeconomic factors on the risk of GCA. Objectives: To further investigate the relation between BMI and GCA, and also assess the role of smoking and socioeconomic factors in this context. Methods: Two population based health-surveys, The Malmö Preventive Medicine Program (MPMP) and the Malmö Diet Cancer Study (MDCS), performed in the same catchment area between 1974 and 1996. In the MPMP, 33346 subjects (33% women), and in the MDCS, 30447 subjects (60% women) were included. Both surveys included standard physical examinations and self-administered questionnaires. Subjects were classified as blue-collar workers or white-collar workers, using the Socioeconomic Index (SEI) based on self-reported job titles in the Swedish national censuses.
Background: Few studies have examined predictors of giant cell arteritis (GCA). A negative association between body mass index (BMI) and development of GCA has been reported (1, 2). There is limited information on the impact of smoking and socioeconomic factors on the risk of GCA. Objectives: To further investigate the relation between BMI and GCA, and also assess the role of smoking and socioeconomic factors in this context. Methods: Two population based health-surveys, The Malmö Preventive Medicine Program (MPMP) and the Malmö Diet Cancer Study (MDCS), performed in the same catchment area between 1974 and 1996. In the MPMP, 33346 subjects (33% women), and in the MDCS, 30447 subjects (60% women) were included. Both surveys included standard physical examinations and self-administered questionnaires. Subjects were classified as blue-collar workers or white-collar workers, using the Socioeconomic Index (SEI) based on self-reported job titles in the Swedish national censuses.
Individuals who developed GCA after inclusion in the two health surveys were identified by linking the health survey databases to local and national patient registers. A structured review of the medical records was performed. Four controls for every validated case, matched for sex, year of birth and year of screening, were selected from the corresponding databases. Potential predictors of GCA were examined in conditional logistic regression models. This is an extension of a previous study, adding more incident cases (2). Results: A total of 138 cases with a confirmed clinical diagnosis of GCA (median age at diagnosis 71 years; 72% female; 66% biopsy-positive; 94% fulfilled the ACR criteria for GCA) were included. The median time from screening to diagnosis was 15 years (range 0-32). The cases who subsequently developed GCA had significantly lower BMI at baseline (24.3 vs 25.3 kg/m 2 , odds ratio (OR) 0.91 per kg/m 2 ; 95% confidence interval (CI) 0.86-0.97) and were less likely to be current smokers when entering the health survey (OR 0.56; 95% CI 0.33-0.94). There was no difference in the proportion with low level of formal education between cases and controls (OR 1.27; 95% CI 0.66-2.44). Blue-collar workers tended to be less likely to develop GCA than white-collar workers (OR 0.53; 95% CI 0.28-1.00). This association reached statistical significance in women (OR 0.32; 95% CI 0.13-0.81) but not in men (OR 0.87; ). In multivariate analysis, including both variables and the SEI, the impact of BMI (OR 0.85; 95% CI 0.74-0.96) and smoking (OR 0.26; 95% CI 0.12-0.60) remained significant. Conclusions: In this study, the negative association between BMI and subsequent GCA was confirmed, and there was an independent protective effect of smoking. Socioeconomic status, reflected by occupation later in life rather than level of formal education, may also influence the risk of developing GCA. Background: A characteristic feature of RA is the presence of autoantibodies (AAB), such as rheumatoid factor (RF) and antibodies against citrullinated peptides (ACPA). RF and ACPA are not only diagnostically helpful but are also prognostic indicators for progression of joint destruction. Objectives: This is an on-going prospective study to investigate the prevalence of AAB in healthy individuals presenting to community health centres and to subsequently determine the incidence of RA in AAB-positive individuals compared to AAB-negative persons over five years considering the presence of certain risk factors. Methods: Blood drawn at the time of the screening examination was anonymously analyzed for the presence of AAB. AAB positive and age and sex matched AAB negative individuals (2 for each AAB positive subject) were enrolled for further assessment at the central outpatient clinic and examined every 6 months over 5 years. Assessment included laboratory testing (AAB, acute phase parameters), questionnaires on nutrition, lifestyle and general health, 28 joint counts (SJC28, TJC28), the health assessment questionnaire (HAQ), and visual analogue scales for pain and global health. Risk factors were analysed by clusters according to EULAR recommendations for terminology of individuals at risk of RA: hereditary, environmental, systemic autoimmunity and unclassified arthritis and the number of clusters per individual was reported at baseline (1). The primary outcome was the development of RA; individuals lost to follow up were telephone-interviewed for signs and symptoms of RA. Results: 4858 sera were obtained from which 148 (3%) were seropositive (14 ACPA, 124 RF, 10 both). 113 individuals (2,3%) were followed over 5 years. 37 (32,7%) were seropositive of whom 32 (28,3%) were RF-positive, 2 (5,4%) were ACPA-positive and 3 (8,1%) positive for both. We found no significant differences in demographics and risk factors between seropositive and seronegative individuals at baseline ( Background: Gout is the most common type of inflammatory arthritis, affecting 2.4% of adults in the UK and is associated with a number of co-morbidities. Our understanding of the association between gout and fracture risk is limited with previous studies offering conflicting results. Objectives: To determine the risk of fracture among gout patients and assess the potential impact of urate-lowering therapy (ULT) on fracture risk. Methods: Utilising primary care records from Clinical Practice Research Datalink we identified patients with gout between 1990 and 2004 who were followed up until 2015. Each gout patient was individually matched to 5 individuals without gout based on age, sex, and registered practice. Absolute rate (AR) of fracture and hazard ratios (HR) were calculated using Cox regression models. We further stratified our analysis by age, gender and ULT prescription. Results: We matched 35,857 patients with incident gout to 148,407 controls. Overall, we found no increased risk of fracture among gout patients compared to controls. However, men with no evidence of ULT had higher absolute risk of fracture compared to controls (AR=39 versus 26 per 10,000 person-years) corresponding to a 23% (HR=1.23; 95% CI 1.12-1.36) increased risk. The risk was particularly high for vertebral (HR=1.50; 95% CI 1.20-1.87) and wrist fracture (HR=1.45; 95% CI 1.21-1.74). Those treated with ULT had a 12% (HR=0.88; 95% CI 0.79-0.98) lower risk of fracture. Similar findings were not observed for women. Conclusions: We found higher risk of vertebral and wrist fractures among men with gout not prescribed ULT. Those prescribed ULT had lower risk of fracture compared to the general population. Further research is needed to understand the role of ULT in fracture prevention.
